SKOPAXI
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87457059 |
| Registration Number | 5373940 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christopher M. Hanes |
| Attorney Docket Number | 82397622/EAM |
| Law Office Assigned | M20 |
| Employee Name | FALK, JONATHAN ROBERT |
Timeline
| 2017-05-19 | Application Filed |
| 2017-10-24 | Published for Opposition |
| 2018-01-09 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-01-09 | Status: Live/Registered |
| 2018-01-09 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Entity Statement | private company limited by shares (prc) |
| Address | 980 Great West Road Brentford, Middles TW89GS GB2 |
| Legal Entity Type | |
| Legal Entity State | GB2 |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | (Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-05-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-05-25 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-08-18 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-08-18 | 4 CNSA O:Outgoing Correspondence |
| ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2017-09-01 | 5 ERRR O:Outgoing Correspondence |
| ELECTRONIC RECORD REVIEW COMPLETE | 2017-09-20 | 6 FIXD O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-10-04 | 7 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-10-24 | 8 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-24 | 9 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-01-09 | 10 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-11-08 | 11 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-11-08 | 12 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-11-08 | 13 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-01-09 | 14 REM1 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-10-06 | 15 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-10-06 | 16 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-10-06 | 17 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-10-06 | 18 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-10-06 | 19 TCCA I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SKOPAXI 98393976 not registered Live/Pending |
GLAXO GROUP LIMITED 2024-02-06 |
 SKOPAXI 87457059 5373940 Live/Registered |
Glaxo Group Limited 2017-05-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 